MS Senate passes medical marijuana; DE legal cannabis bill filed; New OH legalization signatures; MO GOP psychedelics bill
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming year and it would really help to know what kind of support we can count on.
- Kelly McQueen: “I am very excited about having access to such great information. I am a Navy veteran and retired law enforcement. I have struggled with PTSD for years! My quality of life didn’t improve until I began using cannabis. I wish that everyone had legal access to cannabis.”
Check us out on Patreon and sign up to give $25/month today:
/ TOP THINGS TO KNOW
The Mississippi Senate voted to legalize medical cannabis despite Gov. Tate Reeves’s (R) veto threat over patient possession limits he thinks are too high. The measure now heads to the House.
Marijuana Moment’s latest analysis looks at the large number of states that are poised to legalize cannabis—and potentially psychedelics—in 2022. Between ballot initiatives and bills in legislatures, advocates see a lot of targets for advancement this year.
Ohio activists say they are “confident” they’ve collected enough signatures to force lawmakers to consider a marijuana legalization measure. An earlier submission was deemed insufficient but they’ve now turned in nearly 30,000 more signatures.
Delaware lawmakers introduced a newly revised marijuana legalization bill that includes key changes to equity provisions meant to help ensure it gets the supermajority level of support needed to pass.
A Missouri Republican representative filed a bill to allow patients with debilitating, life-threatening or terminal illnesses to use psychedelics like MDMA, DMT, ibogaine, LSD, mescaline, peyote and psilocybin under the state’s right-to-try law.
The U.S. Sentencing Commission published a report on recidivism by people released from prison after serving time for drug trafficking convictions.
Rep. Barbara Lee (D-CA) tweeted, “The criminalization of cannabis has resulted in discrimination and injustice. Moreover, it has destroyed countless Black and Brown lives. It’s long past time for the federal government to catch up and move our country forward by leading on cannabis reform.”
Rep. Dean Phillips (D-MN) tweeted about a study showing cannabinoids can protect cells from COVID, saying, “As if we needed another reason to legalize it.”
Rep. Nancy Mace (R-SC) spoke about growing Republican support for marijuana reform.
Rep. Jay Obernolte (R-CA) tweeted, “January is Human Trafficking Prevention Month. With cases of human trafficking linked to illegal marijuana cultivation sites rising in our community, it is critical we put an end to this modern-day slavery.”
Wisconsin Democratic Senate candidate Gillian Battino tweeted. “When I am in the Senate, I will fight to legalize recreational marijuana. We can invest tax revenues in communities torn apart by the war on drugs, farmers can diversify with sustainable practices, and patients will have the access they require.”
Texas Democratic congressional candidate Arthur DIxon tweeted, “Rich white business owners profit $100+ Billions Dollars from the cannabis industry every year while here in Texas thousands of black and brown kids get thrown into prison for possessing a few grams… We have to do better! It’s time to legalize marijuana! 🪴”
Kentucky Democratic congressional candidate William Compton tweeted, “One thing I would want to do in congress is make sure Marijuana is legalized nationwide. A majority of people support it! It’s a no brainer.”
Virginia Gov. Ralph Northam touted his signing a marijuana legalization bill in his final State of the Commonwealth speech,
Wisconsin Gov. Tony Evers (D) pardoned more people for marijuana and drug convictions.
California’s attorney general continued to criticize local officials’ slowness to clear marijuana convictions as required by a law he authored.
South Carolina’s Senate majority leader said it’s “time to have the debate” on a long-pending medical cannabis bill, and the House minority leader said it should have been done a long time ago.
The chairman of the Louisiana legislature’s Medical Marijuana Commission said it’s time to expand the medical cannabis program “in every direction.”
Florida Democratic lawmakers held a press conference to promote marijuana legalization bills.
Kansas House Democrats tweeted, “Kansas is 1 of 4 states where marijuana remains fully illegal. It’s 2021. This is unacceptable.”
A Missouri Republican representative discussed plans to file a marijuana legalization bill.
Maine regulators proposed medical cannabis rules changes.
New York regulators proposed emergency hemp rules.
Nevada regulators are conducting a survey to collect demographic data on the cannabis industry.
Illinois officials are hiring reviewers for grant applications for the marijuana revenue-funded Restore, Reinvest, and Renew grant program.
Pennsylvania regulators tweeted about eggs from hemp-fed chickens, saying, “Eating hemp eggs will not get you high, but you will be filled with a healthier egg.”
Marijuana Moment is already tracking more than 900 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
Denver, Colorado officials sent guidance on marijuana hospitality and unlicensed consumption businesses.
Costa Rican lawmakers sent President Carlos Alvarado a medical cannabis and hemp bill.
Grenada Prime Minister Dr Keith Mitchell said his government will introduce a medical cannabis bill ahead of the next election.
The French Assembly debated a marijuana legalization bill.
UK members of Parliament sent a letter asking London’s mayor to rescind a plan to reduce marijuana arrests.
/ SCIENCE & HEALTH
A study concluded that “consumers are interested in and are using [medical cannabis products] for dermatologic indications, most commonly for inflammatory skin disorders.”
A study demonstrated that “treatment with three infusions of ketamine was well tolerated in patients with alcohol use disorder and was associated with more days of abstinence from alcohol at 6-month follow-up.”
/ ADVOCACY, OPINION & ANALYSIS
The Michael J. Fox Foundation’s senior vice president for public policy joined the board of the Council for Federal Cannabis Regulation.
Supernova Women organized a rally at the California Capitol calling for tax and regulatory relief for marijuana businesses.
Eaze opened its first dispensary storefronts.
Vangst completed a $19 million Series B funding round.
Charlotte’s Web Holdings, Inc. completed an organizational restructuring.
Canopy Growth USA is being sued over claims that its website violates the Americans with Disabilities Act by being inaccessible to visually impaired and blind customers.
Leafly has a new senior vice president of engineering.
Jimmy Kimmel and Stephen Colbert joked about a study showing cannabinoids can protect cells from COVID,
The Onion joked about rising COVID vaccine appointments in Quebec, Canada after officials made the shots mandatory to access marijuana and liquor stores.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Photo courtesy of Chris Wallis/Side Pocket Images.
The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.